26
Participants
Start Date
December 2, 2012
Primary Completion Date
October 24, 2017
Study Completion Date
April 29, 2019
Laboratory Biomarker Analysis
Correlative studies
Paclitaxel Albumin-Stabilized Nanoparticle Formulation
Given IV
Bozeman Deaconess Hospital, Bozeman
Group Health Cooperative, Redmond
Fred Hutch/University of Washington Cancer Consortium, Seattle
Skagit Valley Hospital, Mount Vernon
Olympic Medical Center, Port Angeles
Multicare Health System, Tacoma
Wenatchee Valley Hospital and Clinics, Wenatchee
Spokane Valley Cancer Center-Mission, Spokane
Kadlec Clinic Hematology and Oncology, Kennewick
Anchorage Oncology Centre, Anchorage
Katmai Oncology Group, Anchorage
Providence Alaska Medical Center, Anchorage
Collaborators (1)
National Cancer Institute (NCI)
NIH
Celgene Corporation
INDUSTRY
University of Washington
OTHER